| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Effect of hemodialysis on the pharmacokinetics of 19-nor-1alpha,25- dihydroxyvitamin D2
|
Cato 3rd, A
|
|
1998
|
32 |
4S2 |
p. S55-S60
6 p.
|
article
|
| 2 |
Effects of 19-nor-1,25(OH)2D2, a new analogue of calcitriol, on secondary hyperparathyroidism in uremic rats
|
Slatopolsky, E
|
|
1998
|
32 |
4S2 |
p. S40-S47
8 p.
|
article
|
| 3 |
Introduction
|
Llach, Francisco
|
|
1998
|
32 |
4S2 |
p. S1-S2
2 p.
|
article
|
| 4 |
Mechanism of vitamin D action and its regulation
|
Dusso, AS
|
|
1998
|
32 |
4S2 |
p. S13-S24
12 p.
|
article
|
| 5 |
Pathogenic, clinical, and therapeutic aspects of secondary hyperparathyroidism in chronic renal failure
|
|
|
1998
|
32 |
4S2 |
p. S3-S12
10 p.
|
article
|
| 6 |
Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2
|
Llach, F
|
|
1998
|
32 |
4S2 |
p. S48-S54
7 p.
|
article
|
| 7 |
Therapy of secondary hyperparathyroidism with 19-nor-1alpha,25- dihydroxyvitamin D2
|
Martin, KJ
|
|
1998
|
32 |
4S2 |
p. S61-S66
6 p.
|
article
|
| 8 |
Vitamin D analogues
|
Brown, AJ
|
|
1998
|
32 |
4S2 |
p. S25-S39
15 p.
|
article
|
Journal description